Zobrazeno 1 - 10
of 14
pro vyhledávání: '"François Tanoh Eboua"'
Autor:
Julie Jesson, Ayoko Ephoevi-Ga, Marie-Hélène Aké-Assi, Sikiratou Koumakpai, Sylvie N’Gbeche, Evelyne Dainguy, Karen Malateste, Hugo Carrié, Marcelline D’Almeida, François Tanoh Eboua, Elom Takassi, Madeleine Amorissani-Folquet, Valériane Leroy, for the IeDEA West African Pediatric Collaboration
Publikováno v:
BMC Nutrition, Vol 7, Iss 1, Pp 1-13 (2021)
Abstract Background Nutritional care is not optimally integrated into pediatric HIV care in sub-Saharan Africa. We assessed the 6-month effect of a nutritional support provided to children living with HIV, followed in a multicentric cohort in West Af
Externí odkaz:
https://doaj.org/article/d647eabcaa584f6b90109e0b499d7f54
Autor:
Marc Harris Dassi Tchoupa Revegue, Unoo Elom Takassi, François Tanoh Eboua, Sophie Desmonde, Ursula Belinda Amoussou-Bouah, Tchaa Abalo Bakai, Julie Jesson, Désiré Lucien Dahourou, Karen Malateste, Hortense Aka-Dago-Akribi, Jean-Philippe Raynaud, Elise Arrivé, Valériane Leroy
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2021)
Background: Adolescents living with perinatally-acquired HIV (APHIV) face challenges including HIV serostatus disclosure. We assessed their 24-month outcomes in relation to the disclosure of their own HIV serostatus.Methods: Nested within the Interna
Externí odkaz:
https://doaj.org/article/8d157f8e18b64be0b2a705b037da9f16
Autor:
Saik Urien, Caroline Yonaba, Jean-Marc Tréluyer, Alain Pruvost, Sophie Desmonde, Désiré Lucien Dahourou, Frantz Foissac, Evelyne Dainguy, Karen Malateste, Claire Pressiat, Déborah Hirt, Valériane Leroy, Naïm Bouazza, François Tanoh Eboua
Publikováno v:
Antiviral therapy. 26(6-8)
Background Few pharmacokinetic data were reported on dispersible tablets despite their increasing use. One hundred fifty HIV-infected children receiving lamivudine were enrolled in the MONOD ANRS 12,206 trial. Three galenic forms were administered: l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f387c9ce010600f81a8a9e2c21bbbc6
https://pubmed.ncbi.nlm.nih.gov/35485334
https://pubmed.ncbi.nlm.nih.gov/35485334
Autor:
Caroline Yonaba, Stéphane Blanche, Hélène Bukuru, Mathurin Cyrille Tejiokem, Sylvie Ouédraogo, François Tanoh Eboua, Madeleine Amorissani Folquet, Aminata Diack, Ida Calixte Penda, Aba Coulibaly, Mariam Sylla
Publikováno v:
The Pediatric infectious disease journal. 39(8)
A cross-sectional study of 358 HIV-1-infected children and adolescents living in Sub-Saharan Africa treated with tenofovir disoproxil fumarate-based regimens for a median of 1.5 interquartile range [0.6-3.1 years] showed a loss of glomerular filtrati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d596ae2db645a67e0f48c3cc64effa90
https://pubmed.ncbi.nlm.nih.gov/32502129
https://pubmed.ncbi.nlm.nih.gov/32502129
Autor:
Stéphane Blanche, François Tanoh Eboua, Valériane Leroy, Karen Malateste, Madeleine Amorissani-Folquet, Jean-Marc Tréluyer, Gabrielle Lui, Déborah Hirt, Diarra Yé, Yi Zheng, Claire Pressiat, Véronique Mea-Assande, Désiré‐Lucien Dahourou, Caroline Yonaba
Publikováno v:
British Journal of Clinical Pharmacology. 83:2729-2740
Aims A clinical study was conduct in HIV-infected children to evaluate the prophylactic doses of cotrimoxazole [sulfamethoxazole (SMX) and trimethoprim (TMP)] advised by the WHO. Methods Children received lopinavir-based antiretroviral therapy with c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42d29115a9b21778fe2bc5208515e47b
https://doi.org/10.1111/bcp.13397
https://doi.org/10.1111/bcp.13397
Autor:
Marc Harris Dassi Tchoupa Revegue, Elom Takassi, François Tanoh Eboua, Sophie Desmonde, Ursula Belinda Amoussou-Bouah, Tchaa Abalo Bakai, Julie Jesson, Désiré Lucien Dahourou, Karen Malateste, Jean-Philippe Raynaud, Elise Arrivé, Valériane Leroy
Background: Adolescents living with perinatally-acquired HIV (APHIV) face challenges including timely disclosure of their HIV-serostatus that was explored in the West-African COHADO cohort. We assessed the 24-month outcomes in COHADO, among APHIV in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::935433bfbd183f7b3f1674a17db3c08f
https://doi.org/10.21203/rs.2.15733/v1
https://doi.org/10.21203/rs.2.15733/v1
Autor:
Karen Malateste, Madeleine Amorissani-Folquet, Naïm Bouazza, Déborah Hirt, Stéphane Blanche, Gabrielle Lui, Jean-Marc Tréluyer, Caroline Yonaba, Sylvie Ouédraogo, François Tanoh Eboua, Frantz Foissac, Désiré Lucien Dahourou, Valériane Leroy, Claire Pressiat, Véronique Mea-Assande
The MONOD ANRS 12206 trial was designated to assess simplification of a successful lopinavir (LPV)-based antiretroviral treatment in HIV-infected children younger than 3 years of age using efavirenz (EFV; 25 mg/kg of body weight/day) to preserve the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8915065fe1baa2922c187bcd4c00ccc
https://europepmc.org/articles/PMC5487686/
https://europepmc.org/articles/PMC5487686/
Autor:
Marguerite Timite-Konan, Nicolas Meda, Roger Salamon, Sylvie Ouédraogo, Madeleine Amorissani-Folquet, Angèle Kalmogho, François Tanoh Eboua, Philippe Van de Perre, Thomas d'Aquin Toni, Sylvie N’Gbeche, Clarisse Amani-Bosse, Malik Coulibaly, Divine Avit, Karen Malateste, Valériane Leroy, Carole Seguin-Devaux, Caroline Yonaba, Stéphane Blanche, Philippe Lepage, Rasmata Ouédraogo, Désiré Lucien Dahourou
Publikováno v:
BMC medicine, 15 (1
BMC Medicine
BMC Medicine, BioMed Central, 2016, 15 (1), pp.85. 〈10.1186/s12916-017-0842-4〉
BMC Medicine, BioMed Central, 2016, 15 (1), pp.85. ⟨10.1186/s12916-017-0842-4⟩
BMC Medicine, 2016, 15 (1), pp.85. ⟨10.1186/s12916-017-0842-4⟩
BMC Medicine, Vol 15, Iss 1, Pp 1-16 (2017)
BMC Medicine
BMC Medicine, BioMed Central, 2016, 15 (1), pp.85. 〈10.1186/s12916-017-0842-4〉
BMC Medicine, BioMed Central, 2016, 15 (1), pp.85. ⟨10.1186/s12916-017-0842-4⟩
BMC Medicine, 2016, 15 (1), pp.85. ⟨10.1186/s12916-017-0842-4⟩
BMC Medicine, Vol 15, Iss 1, Pp 1-16 (2017)
Background: The 2016 World Health Organization guidelines recommend all children
0
SCOPUS: ar.j
info:eu-repo/semantics/published
0
SCOPUS: ar.j
info:eu-repo/semantics/published
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d784a757854c06dbaa154fc03ecd294e
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/259613
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/259613
Autor:
Michael Schomaker, Vivian Cox, Geneviève Chêne, Haby Sygnaté-Sy, Fla Kouéta, Madeleine Amorissani-Folquet, Valériane Leroy, Cleophas Chimbetete, Karl-Günter Technau, María Luisa Navarro, Josiane Warszawski, Shobna Sawry, Sam Phiri, Tom F.W. Wolfs, Mary-Ann Davies, Lorna Renner, Clarisse Amani-Bosse, Janet Giddy, Dorthe Raben, Sylvie N’Gbeche, Ali Judd, Frank Tanser, François Tanoh Eboua, Antoni Noguera-Julian
Publikováno v:
International Journal of Epidemiology, 46(2), 453. Oxford University Press
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Background: There is limited knowledge about the optimal timing of antiretroviral treatment initiation in older children and adolescents. Methods: A total of 20 576 antiretroviral treatment (ART)-naïve patients, aged 1-16 years at enrolment, from 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49c4a145e2cc13c79f30770d6acc7ace
https://dspace.library.uu.nl/handle/1874/360216
https://dspace.library.uu.nl/handle/1874/360216
Autor:
Sophie Desmonde, Marguerite Timite-Konan, Sylvie N’Gbeche, Véronique Mea, Evelyne Dainguy, François Tanoh Eboua, Andrea L. Ciaranello, Valériane Leroy, Divine Avit, Junie Petit, Madeleine Amorissani Folquet, Clarisse Amani Bosse
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 12, p e0166466 (2016)
PLoS ONE, Vol 11, Iss 12, p e0166466 (2016)
OBJECTIVES:To access the costs of care for Ivoirian children before and after initiating LPV/r-based antiretroviral therapy (ART) before the age of two. METHODS:We assessed the direct costs of care for all HIV-infected children over the first 12 mont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f812ccab8b48dad460af1cd562164c0
http://europepmc.org/articles/PMC5147813
http://europepmc.org/articles/PMC5147813